Critical role of diagnostic SARS-CoV-2 T cell assays for immunodeficient patients.

Ameratunga, Rohan; Woon, See-Tarn; Steele, Richard; Lehnert, Klaus; Leung, Euphemia; Brooks, Anna E S

Ameratunga, Rohan; Woon, See-Tarn; Steele, Richard; Lehnert, Klaus; Leung, Euphemia; Brooks, Anna E S.

Afiliación

Ameratunga R; Department of Virology and Immunology, Auckland City Hospital, Auckland, New Zealand rohana@adhb.govt.nz.
Woon ST; Department of Clinical Immunology, Auckland City Hospital, Auckland, New Zealand.
Steele R; Department of Virology and Immunology, Auckland City Hospital, Auckland, New Zealand.
Lehnert K; Department of Clinical Immunology, Wellington Hospital, Wellington, New Zealand.
Leung E; Centre for brain Research, University of Auckland, Auckland, New Zealand.
Brooks AES; Cancer Research, Faculty of Medical and health Sciences, School of Medicine, University of Auckland, Auckland, New Zealand.

J Clin Pathol ; 75(12): 793-797, 2022 Dec.

Article en En | MEDLINE | ID: mdl-36216482

Asunto(s)

COVID-19; SARS-CoV-2; Humanos; COVID-19/diagnóstico; Anticuerpos Antivirales; Pandemias; Síndrome Post Agudo de COVID-19

Palabras clave

COVID-19; Cell Proliferation; Immunoglobulins

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Clin Pathol Año: 2022 Tipo del documento: Article País de afiliación: Nueva Zelanda

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google